• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

TOPAZ-1: a new standard of care for advanced biliary tract cancers?

作者信息

Ebia Matthew I, Sankar Kamya, Osipov Arsen, Hendifar Andrew E, Gong Jun

机构信息

Department of Medicine, Division of Hematology & Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA 90048, USA.

出版信息

Immunotherapy. 2023 May;15(7):473-476. doi: 10.2217/imt-2022-0269. Epub 2023 Mar 23.

DOI:10.2217/imt-2022-0269
PMID:36950948
Abstract
摘要

相似文献

1
TOPAZ-1: a new standard of care for advanced biliary tract cancers?TOPAZ-1：晚期胆管癌的一种新的治疗标准？
Immunotherapy. 2023 May;15(7):473-476. doi: 10.2217/imt-2022-0269. Epub 2023 Mar 23.
2
Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology.二线FOLFOX并非所有晚期胆管癌患者的标准治疗方案——来自国际老年肿瘤学会青年部的评论
Ann Oncol. 2023 Jun;34(6):555-556. doi: 10.1016/j.annonc.2023.02.007. Epub 2023 Feb 21.
3
Current and emerging immunotherapeutic approaches for biliary tract cancers.当前和新兴的胆管癌免疫治疗方法。
Hepatobiliary Pancreat Dis Int. 2022 Oct;21(5):440-449. doi: 10.1016/j.hbpd.2022.08.015. Epub 2022 Sep 7.
4
Immune checkpoint inhibitors in cholangiocarcinoma.胆管癌中的免疫检查点抑制剂
Immunotherapy. 2023 May;15(7):541-551. doi: 10.2217/imt-2022-0288. Epub 2023 Apr 25.
5
Immunotherapy in Biliary Tract Cancers: Where Are We?胆管癌的免疫治疗：我们在哪里？
Curr Oncol Rep. 2022 Dec;24(12):1821-1828. doi: 10.1007/s11912-022-01328-7. Epub 2022 Oct 4.
6
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.一项关于尿嘧啶替加氟联合多柔比星治疗不可切除胆管癌患者的II期研究及预后因素
Cancer Chemother Pharmacol. 2009 Dec;65(1):113-20. doi: 10.1007/s00280-009-1011-z. Epub 2009 Apr 29.
7
Durvalumab in advanced cholangiocarcinoma: is someone knocking down the door?度伐利尤单抗治疗晚期胆管癌：有人在敲门吗？
Immunotherapy. 2023 May;15(7):477-486. doi: 10.2217/imt-2022-0301. Epub 2023 Mar 23.
8
Second-line fluoropyrimidine-based doublet chemotherapy for advanced biliary tract cancer: a new standard of care?晚期胆管癌的二线氟嘧啶类双联化疗：一种新的治疗标准？
Expert Rev Gastroenterol Hepatol. 2022 Mar;16(3):201-203. doi: 10.1080/17474124.2022.2047652. Epub 2022 Mar 2.
9
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.替加氟尿嘧啶联合多柔比星治疗不可切除晚期胆管癌的II期早期研究。
Jpn J Clin Oncol. 2006 Sep;36(9):552-6. doi: 10.1093/jjco/hyl075. Epub 2006 Aug 3.
10
Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer.仑伐替尼联合 PD-1/PD-L1 抑制剂加 Gemox 化疗治疗晚期胆道癌的疗效和安全性。
Front Immunol. 2023 Jan 18;14:1109292. doi: 10.3389/fimmu.2023.1109292. eCollection 2023.

引用本文的文献

1
Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer.经动脉化疗栓塞联合度伐利尤单抗治疗晚期和转移性胆管癌的临床疗效
Future Sci OA. 2025 Dec;11(1):2526947. doi: 10.1080/20565623.2025.2526947. Epub 2025 Jul 4.
2
Machine learning-driven prediction of immune checkpoint inhibitor responses against cholangiocarcinoma: a bile biopsy perspective.机器学习驱动的针对胆管癌的免疫检查点抑制剂反应预测：胆汁活检视角
Front Immunol. 2025 Jun 16;16:1614683. doi: 10.3389/fimmu.2025.1614683. eCollection 2025.
3
PARP inhibitor and immune checkpoint inhibitor have synergism efficacy in gallbladder cancer.
聚腺苷二磷酸核糖聚合酶抑制剂和免疫检查点抑制剂在胆囊癌中具有协同疗效。
Genes Immun. 2024 Aug;25(4):307-316. doi: 10.1038/s41435-024-00280-9. Epub 2024 Jun 12.
4
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?联合治疗克服肝癌免疫检查点阻断耐药：强强联手？
Semin Liver Dis. 2024 May;44(2):159-179. doi: 10.1055/a-2334-8311. Epub 2024 May 28.
5
The State of Systematic Therapies in Clinic for Hepatobiliary Cancers.肝胆癌临床系统治疗现状
J Hepatocell Carcinoma. 2024 Mar 27;11:629-649. doi: 10.2147/JHC.S454666. eCollection 2024.
6
Globo H ceramide is an independent prognostic marker for gallbladder cancer.Glob H神经酰胺是胆囊癌的一个独立预后标志物。
Am J Cancer Res. 2023 Oct 15;13(10):4811-4821. eCollection 2023.